Cathy Davies
Affiliations: | Department of Psychosis Studies | King's College London, London, UK |
Area:
Psychosis, MRI, MemoryWebsite:
https://kclpure.kcl.ac.uk/portal/cathy.davies.htmlGoogle:
"Cathy Davies"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Paolo Fusar-Poli | grad student | King's College | |
| Philip McGuire | grad student | King's College |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Davies C, Martins D, Dipasquale O, et al. (2024) Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin. Molecular Psychiatry |
| Davies C, Bossong MG, Martins D, et al. (2023) Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol. Psychological Medicine. 1-11 |
| Oliver D, Davies C, Zelaya F, et al. (2023) Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study. Frontiers in Psychiatry. 14: 1092213 |
| Gunasekera B, Davies C, Blest-Hopley G, et al. (2022) Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression: A neuroimaging meta-regression analysis. Neuroscience and Biobehavioral Reviews. 140: 104801 |
| Fusar-Poli P, Radua J, Davies C, et al. (2021) Overoptimistic Literature and Methodological Biases Favoring Cognitive Behavioral Therapy for the Prevention of Psychosis. Schizophrenia Bulletin |
| Davies C, Appiah-Kusi E, Wilson R, et al. (2021) Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report. European Archives of Psychiatry and Clinical Neuroscience |
| de Pablo GS, Davies C, de Diego H, et al. (2021) Transition to psychosis in randomised clinical trials of individuals at clinical high risk of psychosis compared to observational cohorts: a systematic review and meta-analysis. European Psychiatry : the Journal of the Association of European Psychiatrists. 1-22 |
| Davies C, Wilson R, Appiah-Kusi E, et al. (2020) A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis. Translational Psychiatry. 10: 311 |
| Fusar-Poli P, Radua J, McKenna PJ, et al. (2020) Methodological Biases in CBT Trial-Commentary: Modular Cognitive-Behavioral Therapy for Affective Symptoms in Young Individuals at Ultra-High Risk of First Episode of Psychosis: Randomized Controlled Trial. Frontiers in Psychiatry. 11: 394 |
| Martins D, Davies C, De Micheli A, et al. (2020) Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study. Translational Psychiatry. 10: 227 |